Alzamend Neuro (ALZN) Debt Ratio (2020 - 2024)
Alzamend Neuro's (ALZN) quarterly Debt Ratio came in at 0.48 in Q2 2024, up 401.7% quarter-over-quarter from 0.09 in Q4 2022.
Analysis
Alzamend Neuro (ALZN) Debt Ratio (2020 - 2024) Analysis & Trends
Alzamend Neuro has disclosed Debt Ratio across 4 years of filings, most recently posting 0.48 for Q2 2024.
- In Q2 2024, Debt Ratio changed N/A year-over-year to 0.48; the TTM figure through Apr 2024 stood at 0.48 (changed N/A YoY), while the FY2024 annual figure was 0.48, changed N/A from the prior year.
- Debt Ratio came in at 0.48 for Q2 2024 at Alzamend Neuro, up from 0.09 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.48 in Q2 2024 to a low of 0.0 in Q2 2022.
- Average Debt Ratio over 4 years is 0.08, with a median of 0.01 recorded in 2021.
- The largest YoY upside for Debt Ratio was 62968.45% in 2022 against a maximum downside of 99.31% in 2022.
- Over 4 years, Debt Ratio stood at 0.03 in 2020, then slumped by 99.56% to 0.0 in 2021, then surged by 62968.45% to 0.09 in 2022, then surged by 401.7% to 0.48 in 2024.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.48 in Q2 2024, 0.09 in Q4 2022, and 0.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.25 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 0.26 |
| 10 | Alzamend Neuro | 5.54 Mn | 5.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2024 | 0.48 |
| Oct 31, 2022 | 0.09 |
| Apr 30, 2022 | 0.00 |
| Jan 31, 2022 | 0.00 |
| Oct 31, 2021 | 0.00 |
| Jul 31, 2021 | 0.00 |
| Apr 30, 2021 | 0.02 |
| Apr 30, 2020 | 0.03 |